Parexel and Palantir to accelerate clinical data delivery and power clinical outcomes for patients
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
New solvent-free micronization technology expanded at the Darmstadt site in Germany
Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
Cellares will dedicate multiple Cell Shuttle and Cell Q systems with fully automated, high-throughput quality control for Bristol Myers Squibb’s exclusive use
The newly issued patent, US Patent No. 11,957,647, provides both expanded scope of protection as well as longer patent term
The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents
Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
Subscribe To Our Newsletter & Stay Updated